Cargando…

Clinical features of anemia in membranous nephropathy patients: a Chinese cohort study

BACKGROUND: Anemia is a common complication in patients with progressive chronic kidney disease. This cohort study evaluated the prevalence, clinical features and prognosis of membranous nephropathy (MN) with anemia. METHODS: We retrospectively analyzed a cohort of MN patients diagnosed using renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhe, Le, Weibo, Zhang, Haitao, Chen, Dacheng, Chen, Wencui, Zhu, Shuhua, Zuo, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946306/
https://www.ncbi.nlm.nih.gov/pubmed/36799117
http://dx.doi.org/10.1080/0886022X.2022.2152692
_version_ 1784892307015729152
author Li, Zhe
Le, Weibo
Zhang, Haitao
Chen, Dacheng
Chen, Wencui
Zhu, Shuhua
Zuo, Ke
author_facet Li, Zhe
Le, Weibo
Zhang, Haitao
Chen, Dacheng
Chen, Wencui
Zhu, Shuhua
Zuo, Ke
author_sort Li, Zhe
collection PubMed
description BACKGROUND: Anemia is a common complication in patients with progressive chronic kidney disease. This cohort study evaluated the prevalence, clinical features and prognosis of membranous nephropathy (MN) with anemia. METHODS: We retrospectively analyzed a cohort of MN patients diagnosed using renal biopsy between February 2012 and February 2018. The clinical and pathological characteristics at baseline were recorded, and the outcomes (hemoglobin, proteinuria and renal function) during follow-ups were also evaluated. Univariate and multivariate logistic regression analyses were performed to identify the independent risk factors for anemia in MN patients. The MN patients were divided according to the therapeutic effect they experienced as follows: without-anemia, completely corrected anemia, standard anemia treatment and nonstandard anemia treatment groups. We compared the rate of complete remission of MN and renal end-point events among the four groups. RESULTS: The median age of 483 patients was 42.43 (26.59, 50.20) years at the time of MN diagnosis. The prevalence of anemia at baseline was 23.81%, and the cumulative prevalence was 50.72%. There were 133 cases of mild anemia, 103 cases of moderate anemia and 9 cases of severe anemia; in addition, there were 228 cases of normocytic anemia and 17 cases of microcytic hypochromic anemia. Multivariate logistic regression indicated that acute renal tubule injury >5% (OR = 1.634, 95% CI 1.034, 2.581; p = 0.035), total protein level (OR = 0.949, 95% CI 0.923, 0.975; p < 0.001), cholesterol level (OR = 0.833, 95% CI 0.749, 0.926, p = 0.001), hypokalemia (OR = 2.612, 95% CI 1.227, 5.560, p = 0.013) and hypophosphatemia (OR = 2.653, 95% CI 1.303, 5.403, p = 0.007) were independent risk factors for anemia in MN patients. The complete remission rate of MN patients without anemia was significantly higher than that of anemia patients who exhibited treatment failure. The incidence of renal endpoint events was different among the four groups. CONCLUSION: The anemia experienced by MN patients is mainly mild and moderate, normocytic anemia. The pathological features of acute renal tubular injury and clinical nutritional status are independent risk factors for anemia. There were differences in renal prognosis among anemia patients with different treatment outcomes.
format Online
Article
Text
id pubmed-9946306
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-99463062023-02-23 Clinical features of anemia in membranous nephropathy patients: a Chinese cohort study Li, Zhe Le, Weibo Zhang, Haitao Chen, Dacheng Chen, Wencui Zhu, Shuhua Zuo, Ke Ren Fail Clinical Study BACKGROUND: Anemia is a common complication in patients with progressive chronic kidney disease. This cohort study evaluated the prevalence, clinical features and prognosis of membranous nephropathy (MN) with anemia. METHODS: We retrospectively analyzed a cohort of MN patients diagnosed using renal biopsy between February 2012 and February 2018. The clinical and pathological characteristics at baseline were recorded, and the outcomes (hemoglobin, proteinuria and renal function) during follow-ups were also evaluated. Univariate and multivariate logistic regression analyses were performed to identify the independent risk factors for anemia in MN patients. The MN patients were divided according to the therapeutic effect they experienced as follows: without-anemia, completely corrected anemia, standard anemia treatment and nonstandard anemia treatment groups. We compared the rate of complete remission of MN and renal end-point events among the four groups. RESULTS: The median age of 483 patients was 42.43 (26.59, 50.20) years at the time of MN diagnosis. The prevalence of anemia at baseline was 23.81%, and the cumulative prevalence was 50.72%. There were 133 cases of mild anemia, 103 cases of moderate anemia and 9 cases of severe anemia; in addition, there were 228 cases of normocytic anemia and 17 cases of microcytic hypochromic anemia. Multivariate logistic regression indicated that acute renal tubule injury >5% (OR = 1.634, 95% CI 1.034, 2.581; p = 0.035), total protein level (OR = 0.949, 95% CI 0.923, 0.975; p < 0.001), cholesterol level (OR = 0.833, 95% CI 0.749, 0.926, p = 0.001), hypokalemia (OR = 2.612, 95% CI 1.227, 5.560, p = 0.013) and hypophosphatemia (OR = 2.653, 95% CI 1.303, 5.403, p = 0.007) were independent risk factors for anemia in MN patients. The complete remission rate of MN patients without anemia was significantly higher than that of anemia patients who exhibited treatment failure. The incidence of renal endpoint events was different among the four groups. CONCLUSION: The anemia experienced by MN patients is mainly mild and moderate, normocytic anemia. The pathological features of acute renal tubular injury and clinical nutritional status are independent risk factors for anemia. There were differences in renal prognosis among anemia patients with different treatment outcomes. Taylor & Francis 2023-02-17 /pmc/articles/PMC9946306/ /pubmed/36799117 http://dx.doi.org/10.1080/0886022X.2022.2152692 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Li, Zhe
Le, Weibo
Zhang, Haitao
Chen, Dacheng
Chen, Wencui
Zhu, Shuhua
Zuo, Ke
Clinical features of anemia in membranous nephropathy patients: a Chinese cohort study
title Clinical features of anemia in membranous nephropathy patients: a Chinese cohort study
title_full Clinical features of anemia in membranous nephropathy patients: a Chinese cohort study
title_fullStr Clinical features of anemia in membranous nephropathy patients: a Chinese cohort study
title_full_unstemmed Clinical features of anemia in membranous nephropathy patients: a Chinese cohort study
title_short Clinical features of anemia in membranous nephropathy patients: a Chinese cohort study
title_sort clinical features of anemia in membranous nephropathy patients: a chinese cohort study
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946306/
https://www.ncbi.nlm.nih.gov/pubmed/36799117
http://dx.doi.org/10.1080/0886022X.2022.2152692
work_keys_str_mv AT lizhe clinicalfeaturesofanemiainmembranousnephropathypatientsachinesecohortstudy
AT leweibo clinicalfeaturesofanemiainmembranousnephropathypatientsachinesecohortstudy
AT zhanghaitao clinicalfeaturesofanemiainmembranousnephropathypatientsachinesecohortstudy
AT chendacheng clinicalfeaturesofanemiainmembranousnephropathypatientsachinesecohortstudy
AT chenwencui clinicalfeaturesofanemiainmembranousnephropathypatientsachinesecohortstudy
AT zhushuhua clinicalfeaturesofanemiainmembranousnephropathypatientsachinesecohortstudy
AT zuoke clinicalfeaturesofanemiainmembranousnephropathypatientsachinesecohortstudy